Hepatitis B Virus E Antigen (HBeAg) antibody (AbBy Fluor® 647)
-
- Target See all Hepatitis B Virus E Antigen (HBeAg) Antibodies
- Hepatitis B Virus E Antigen (HBeAg)
-
Reactivity
- Hepatitis B Virus (HBV), Virus
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- AbBy Fluor® 647
-
Application
- Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Cross-Reactivity
- Virus
- Cross-Reactivity (Details)
- Hepatitis B Virus
- Purification
- Purified by Protein G.
- Immunogen
- HBeAg full length protein
- Clone
- 2E9
- Isotype
- IgG
- Top Product
- Discover our top product HBeAg Primary Antibody
-
-
- Application Notes
- IF(IHC-P) 1:50-200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Expiry Date
- 12 months
-
- Target
- Hepatitis B Virus E Antigen (HBeAg)
- Abstract
- HBeAg Products
- Synonyms
- precore; HBe antigen; PreC; HBeAg; precore protein; external core antigen; HBeAg; p25 antibody, C antibody
- Target Type
- Viral Protein
- Background
-
Synonyms: Hepatitis B, Core antigen, Core protein, HBe antigen, HBeAg, HBVgp4, Pre C,C, Precore protein, Precore/core, Precore/core ORF, Precore/core protei, HBEAG_HBVD3, External core antigen, HBeAg, p25.
Background: Hepatitis B e-antigen (HBeAg) is a viral protein associated with HBV infections. Unlike the surface antigen, the e-antigen is found in the blood only when there are viruses also present. When the virus goes into hiding,? the e-antigen will no longer be present in the blood. HBeAg is often used as a marker of ability to spread the virus to other people (infectivity). Measurement of e-antigen may also be used to monitor the effectiveness of HBV treatment, successful treatment will usually eliminate HBeAg from the blood and lead to development of against e-antigen (anti-HBe). There are some types (strains) of HBV that do not make e-antigen, these are especially common in the Middle East and Asia. In areas where these strains of HBV are common, testing for HBeAg is not very useful.
-